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TO THE EDITOR: 
Mr. Carson makes several important and pithy points with which we agree. 
However, there is 1 overarching point that we read into his response to our 
article “Choosing Health, Choosing Treatment: Patient Choice After 
Diagnosis of Localized Prostate Cancer,”1 that how health services are to 
support patients in making choices is still to be decided and is therefore an 
important point of discussion. To continue this discussion, we want to 
follow-up Carson’s comment about the role of nurses in supporting patient 
choice and his suggestion about in- cluding clinical epidemiologists in 
multidisciplinary teams (MDTs). 
Please forgive us if we gave the impression that a clinical nurse specialist 
would be unbiased when discussing treatment options. We would not wish 
to suggest that anyone—nurses, medical students, clinical epidemiolo- 
gists—could transcend their subjectivity to become objective. Rather than 
asking who will be least biased, we should instead consider the 
implementation of processes that will better allow health professionals to 
support patients in their decision-making. The qualitative research of 
recruitment into the ProtecT trial2 may prove particularly important because 
it provides suggestions for achieving equipoise in the presentation of 
treatment options. 
The suggestion that Clinical Epidemiologists may sup- port MDTs is 
interesting. One would hope that the practice of evidence-based medicine 
(EBM) is now the bedrock of clinical decision-making. Perhaps clinicians 
need support from a designated expert to search evidence for immediate 
clinical application. We wonder if research on patients’ experiences and 
other qualitative evidence would add much of practical benefit for an MDT 
to consider. Unfortunately, those that attempt to search for research on 
patients’ experiences will find that there is little to help them yet. One 
resource, for example, http://healthtalkonline.org (previously the database 
of pa- tients’ experiences; DIPEx), will be useful for health professionals 
and patients alike. Perhaps we could substi- tute clinical epidemiology with 
research on patients’ ex- periences, or find some way to integrate them. 
Localized prostate cancer is all about uncertainty. Current clinical 
knowledge does not yet translate into information that comes close to 
resolving decisional doubt or conflict. 
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